This is an extremely high yield of TRMNs, and parenthetically, is surprisingly comparable with the 4 human melanoma neoepitopes (out of 11 identified by MS) which were observed to elicit a CD8+ T cell response (21). The gene discussed is CD8A; the disease is melanoma.